An Integrated Approach to Biomarker Discovery
One of the main challenges of biomarker discovery is the unbiased evaluation and rational selection of most promising biomarkers suitable for independent validation. The absence of a robust evaluation procedure can result in selecting too many biomarkers (thus creating multiplicity problems) with biased and often too optimistic estimates of performance and with limited clinical utility.
- How some of the major challenges of biomarker discovery can be addressed in an integrated manner.
- How to discover and select the biomarker models most suitable for independent validation.
- The importance of functional analysis as an essential component of biomarker discovery.
Diagnostic Services
Your global partner for biomarker discovery, development & commercialization.
Genomic Services
We offer a range of genomics platform and chemistry options, alongside expert data sciences support and a full sample management service.
Clinical Trial Assays
Comprehensive development, validation & delivery service for research and clinical use assays from our global clinical laboratories in USA, Europe and APAC.
Companion Diagnostics
A collaborative Companion Diagnostic partnership approach with a deep understanding of client needs. We offer CDx development, manufacture & commercialization services.
